Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why does this company suck so bad? Why dont they sell a patent or two to us? I’m certain a few of the brains on this board can run things better - what would they sell them for? Anybody have any clue? Any value at all?
Didnt they clear up the debt last year when they hired the Fortune 500 sales guys?
CELZ SMELLZ
Could be drugs and or alcohol ... only explanation
This company doesnt spend a dime on R&D, they treat investors like garbage, they operate out of a home that has a For Sale sign in front - It was dumb to take them seriously ever - I call it criminally incompetent - the CFO has a current LinkedIn account profile which boasts maintaining a “50 Million Market Cap” at Celz while completing multiple rounds of “successful financing” - now if that doesnt make you LOL then I dont know what will.
When does the K come out?
What is current AS? I thought it was 40,000,000 for a minute
How much was paid to UclaBiolabs and when will they post results? These guys need to provide some answers
Obviously they are on to something HUGE - just look at that market cap! by the way, what happened to the “fountain of youth” therapy they had?
There is not a soul in the world that would short a micro-cap stock with a total market cap less than a condo - get real
Which celz exec is taking kit orders and getting them delivered on time to doctors via Ranfac? Wish we had a clue how this operation is supposed to work and what their capacity to handle any significant demand is ...
THEY PROMISED AND THEY DELIVERED
And so what was the response when you asked?
“Waiting on the paper is out of the way?” Nobody has been waiting on the paper we have been waiting on the UCLA Dr Rajfer to provide results - what happened to that?
Why doesn’t this company spend a dime on R&D?
Still no mention of Dr Rajfer’s UCLA trial ever concluding? At least they are “legally complaint” lol wow
When will we hear from Dr Rajfer? Is he now just a footnote in the acknowledgements section of the JofTM publication?
When will this company provide a business plan or model or anything that is of value?
Scalability is the key question and concern - cmth has not addressed any real plan to grow.
Let’s see the link
Hey man seriously - give this management a break - they promised and they delivered after having the most productive quarter ever! - so when will the quarterly results be announced so we can see what they are talking about?
Ok but how many shares will be outstanding? What would the share price be at $50million market-cap where it started 2017?
That’s a real reply - I can tell because Donald Dickerson had that same tone with me - it is obvious why they have zero shareholder support and the stock is now worthless - Great work by a dude with an online education
Why? A RS is only bad if the company is a scam - either it is undervalued currently or it is not - share structure has little to do with anything except marketability of shares .
Yup just 4 dudes like Dr Rajfer are involved ... rrrrright.... lol
What is “the little birdie channel???”
You are profoundly off base - that doctor is now a “principal investigator” alongside Dr Rajfer according to the government mandated trial study site so that’s probably what he has been busy with lol that’s not one of my worries
What if the clinical data says that the Caverstem procedure is safe and with a better than 60% success rate for normally untreatable cases? I think that’s why I am still here lol
Imagine a day the measly $1.8 million in convertible debt is extinguished with a proper sale transaction or business contract and it is free of that criticism and pps destroyer - it is a nice dream
Wow - impressive !! Great timing to see you here again
Gershman is now listed as a lead investigator along with Rajfer so that answers that part at least - that may be the most important part
Im surprised there is any bid at all these guys have proven to be irresponsible and reckless with their debt and share management and show no interest in addressing shareholder concerns directly and operate behind a veil of secrecy so the only thing that will improve the valuation is a fundamental change such as a buy out because they have zero credibility with anybody outside of the science community
LOL
Gotta see this thru at least the trials we’ve waited this long - if they are good and safe results then why not $500m - $1 bill valuation?
Ok so it is a good sign that changes were made on the government regulated LABiomed website so that tells us that the study is alive and well and we are just waiting for peer reviewed results which in all likelihood will change the valuation very quickly but the fiscal management, corporate identity and competency are the real issues at stake here .. the ace in the hole consisting of trial data may just be the rabbit in the hat but it seems like even that could be drowned out with more management shenanigans like incorrect filings or another share structure announcement or undertaking of clown debt that shows nothing for shareholder value or interests.. no solid communications from management about planning and intent or even corporate whereabouts makes this look like a sham - that’s where we are at.
GTSM---This is a newly formed market maker, that most have not noticed.
What makes them special is, they have institution clients in addition to OTC clients... camouflage for the whales
If by some stroke of luck there comes solid trial data, and from that they joined forces with a big company, then the valuation would change at lightning speed - this torture chamber could turn into a rocket ship with the right fuel
This event should help the resident fundamental analysts put together an estimated market value for the IP portfolio and most likely value it all well above the current market cap - just a hopeful hunch!
https://endpts.com/bayer-is-going-all-in-on-next-gen-stem-cell-biotech-bluerock-buying-out-versant-and-founders-for-600m/
I think they are playing it safe and on a shoestring budget - if the procedures are legitimate for a portion of the global markets, and if it has an actual moat around the intellectual property to keep others from copying or creating something better with ease, then the true value should shine thru one way or another one day hopefully within next 2 years is my guess
Seriously LOL
These dudes need to get with modern times - there is no way that amateur stuff will sell procedures or stock or whatever they are trying to sell so why do they waste their time making this stuff??? total head-scratcher - baffling that a company with supposedly a revolutionary procedure cant make a proper commercial
This is great work all around thanks JB - really puts things into perspective
Let’s hear some details - I don’t care about how awkward or uncomfortable it is - are you able to perform noticeably better yes or no? Has it helped your confidence? Would you recommend the procedure to a friend? And finally, what was her name - was she hot?